Dr. Reddy's Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Dr. Reddy's Laboratories Limited generated cash of $45,433,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$3,763,000,000 last year. Net change in cash is therefore $1,328,000,000.
Cash Flow
| 2010 | 13.22B | -6.99B | -5.30B |
|---|---|---|---|
| 2011 | 8.00B | -8.65B | -377M |
| 2012 | 16.15B | -18.66B | 3.73B |
| 2016 | 41.24B | -20.42B | -17.00B |
| 2018 | 18.02B | -14.88B | -4.44B |
| 2020 | 29.84B | -4.92B | -25.15B |
| 2021 | 35.70B | -22.66B | -298M |
| 2023 | 58.87B | -41.37B | -26.86B |
| 2024 | 45.43B | -40.28B | -3.76B |
DRREDDY.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.77B | 14.85B | 1.96B | 2.22B | 3.77B | 5.39B | 5.66B | 6.54B | 5.37B |
Operating activities | |||||||||
Net income | 55.68B | 60.48B | 19.14B | 19.49B | 9.80B | 20.01B | 14.26B | 11.04B | 1.06B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 14.84B | 12.50B | 12.79B | 12.47B | 11.71B | 10.25B | 5.21B | 4.14B | 4.16B |
Stock-based compensation expense | 407M | 397M | 584M | 521M | 454M | 471M | 326M | 265M | 226M |
| Deferred income tax benefit | 407M | 397M | 584M | 521M | 454M | 471M | 326M | 265M | 226M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -8.05B | -5.75B | 2.08B | -12.44B | -2.09B | 833M | 0 | -4.57B | 900M |
Inventories | -18.44B | -2.65B | -9.88B | -1.48B | -3.23B | -2.52B | -4.34B | -3.62B | -1.59B |
Accounts payable | 3.46B | 23M | 2.86B | 1.57B | 2.50B | 746M | 0 | 0 | 0 |
Cash generated by operating activities | 45.43B | 58.87B | 35.70B | 29.84B | 18.02B | 41.24B | 16.15B | 8.00B | 13.22B |
Investing activities | |||||||||
Purchases Of Investments | -145.48B | -136.17B | -75.41B | -111.91B | -68.42B | -68.24B | -26.30B | -8.96B | -24.11B |
Investments In Property Plant And Equipment | -27.43B | -18.86B | -12.56B | -6.11B | -11.04B | -14.87B | -6.85B | -9.06B | -4.12B |
Acquisitions Net | -12M | 23.36B | -15.51B | 214M | 1.75B | -7.93B | 0 | -1.16B | 0 |
Cash generated by investing activities | -40.28B | -41.37B | -22.66B | -4.92B | -14.88B | -20.42B | -18.66B | -8.65B | -6.99B |
Financing activities | |||||||||
Common Stock Issued | 805M | 368M | 269M | 4M | 1M | 1M | 6M | 29M | 17M |
Payments for dividends | -6.64B | -4.97B | -4.14B | -3.91B | -3.99B | -4.10B | -2.21B | -3.06B | -1.23B |
Repurchases of common stock | 0 | 0 | -1.19B | -474M | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 4.34B | -19.38B | -4.49B | -23.4B | 882M | -11.97B | 0 | -14.07B | -4.01B |
Cash used in financing activities | -3.76B | -26.86B | -298M | -25.15B | -4.44B | -17.00B | 3.73B | -377M | -5.30B |
Net Change In Cash | 1.32B | -9.07B | 12.85B | -266M | -1.23B | -473M | 1.71B | -885M | 1.16B |
Cash at end of period | 7.10B | 5.77B | 14.82B | 1.96B | 2.54B | 4.92B | 7.37B | 5.66B | 6.54B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |